Hepatosplenic T-Cell lymphoma on Biologic Therapy for Inflammatory Bowel Disease: A Systematic Review of the Literature and FDA Adverse Event Reporting System

The American Journal of Gastroenterology ◽

10.14309/00000434-201710001-00700 ◽

2017 ◽

Vol 112 ◽

pp. S387

Author(s):

Eric D. Shah ◽

Anil Nayyar ◽

Kerry Jo Lee

Keyword(s):

Systematic Review ◽

Reporting System ◽

Biologic Therapy ◽

Cell Lymphoma ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Review Of The Literature ◽

Event Reporting ◽

Hepatosplenic T Cell Lymphoma ◽

Inflammatory Bowel

Download Full-text

Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.15637 ◽

2020 ◽

Vol 51 (5) ◽

pp. 527-533 ◽

Cited By ~ 6

Author(s):

Eric D. Shah ◽

Elliot S. Coburn ◽

Anil Nayyar ◽

Kerry Jo Lee ◽

Jenna L. Koliani-Pace ◽

...

Keyword(s):

Systematic Review ◽

Inflammatory Bowel Disease ◽

Reporting System ◽

Biologic Therapy ◽

Cell Lymphoma ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Hepatosplenic T Cell Lymphoma ◽

Inflammatory Bowel

Download Full-text

Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn’s disease medications and hepatosplenic T-cell lymphoma

Systematic Reviews ◽

10.1186/2046-4053-2-53 ◽

2013 ◽

Vol 2 (1) ◽

Cited By ~ 16

Author(s):

Saranya A Selvaraj ◽

Elizabeth Chairez ◽

Lisa M Wilson ◽

Mark Lazarev ◽

Eric B Bass ◽

...

Keyword(s):

Adverse Event ◽

T Cell ◽

Systematic Reviews ◽

Reporting System ◽

Cell Lymphoma ◽

Case Reports ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Hepatosplenic T Cell Lymphoma

Download Full-text

Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS)

Drug Safety - Case Reports ◽

10.1007/s40800-015-0018-0 ◽

2015 ◽

Vol 2 (1) ◽

Cited By ~ 5

Author(s):

Katherine J. Hahn ◽

Shannon J. Morales ◽

James H. Lewis

Keyword(s):

Adverse Event ◽

Case Report ◽

Liver Injury ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Review Of The Literature ◽

Event Reporting

Download Full-text

Analysis of Drug-induced Liver Injury Reported with Tumor Necrosis Factor-alpha Inhibitors to the Food and Drug Administration Adverse Event Reporting System in Inflammatory Bowel Disease

The American Journal of Gastroenterology ◽

10.14309/00000434-201310001-01705 ◽

2013 ◽

Vol 108 ◽

pp. S513

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Drug Induced ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Drug Induced Liver Injury ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Alleged isotretinoin-associated inflammatory bowel disease: Disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2013.04.031 ◽

2013 ◽

Vol 69 (3) ◽

pp. 393-398 ◽

Cited By ~ 16

Author(s):

Derrick J. Stobaugh ◽

Parakkal Deepak ◽

Eli D. Ehrenpreis

Keyword(s):

Inflammatory Bowel Disease ◽

Adverse Event ◽

Drug Administration ◽

Bowel Disease ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Inflammatory Bowel

Download Full-text

Differentiating the Risk of Bacterial Infections between Individual Tumor Necrosis Factor-alpha (TNF-α) Blockers in Inflammatory Bowel Disease: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS)

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01608 ◽

2012 ◽

Vol 107 ◽

pp. S649-S650

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Bacterial Infections ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Tnf Α ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Su1158 Risk of Leukemia With Pharmacotherapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System

Gastroenterology ◽

10.1016/s0016-5085(13)61525-5 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-414

Author(s):

Parakkal Deepak ◽

Derrick J. Stobaugh ◽

Eli D. Ehrenpreis

Keyword(s):

Inflammatory Bowel Disease ◽

Adverse Event ◽

Drug Administration ◽

Bowel Disease ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Inflammatory Bowel

Download Full-text

Su1154 Maternal and Fetal Adverse Outcomes With Tumor Necrosis Factor Alpha Inhibitors in Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System

Gastroenterology ◽

10.1016/s0016-5085(13)61521-8 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-413 ◽

Cited By ~ 2

Author(s):

Parakkal Deepak ◽

Derrick J. Stobaugh ◽

Eli D. Ehrenpreis

Keyword(s):

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Adverse Outcomes ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Concomitant Antibiotic Usage Does Not Further Increase the Risk of Inflammatory Bowel Disease with Isotretinoin Treatment for Acne: A Review of the Food and Drug Administration Adverse Event Reporting System

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01596 ◽

2012 ◽

Vol 107 ◽

pp. S645

Author(s):

Derrick Stobaugh ◽

Parakkal Deepak ◽

Eli Ehrenpreis

Keyword(s):

Inflammatory Bowel Disease ◽

Adverse Event ◽

Drug Administration ◽

Bowel Disease ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Antibiotic Usage ◽

Event Reporting ◽

Inflammatory Bowel

Download Full-text

Analysis of the Food and Drug Administration Adverse Event Reporting System to Examine the Relationship between Tumor Necrosis Factor Alpha Inhibitor Therapy and Congestive Heart Failure among Patients with Inflammatory Bowel Disease

The American Journal of Gastroenterology ◽

10.14309/00000434-201310001-01726 ◽

2013 ◽

Vol 108 ◽

pp. S520-S521

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Inflammatory Bowel ◽

Factor Alpha ◽

The Relationship ◽

Necrosis Factor

Download Full-text